KR20190066017A - 연속식 바이러스 제거의 검증 - Google Patents

연속식 바이러스 제거의 검증 Download PDF

Info

Publication number
KR20190066017A
KR20190066017A KR1020197010823A KR20197010823A KR20190066017A KR 20190066017 A KR20190066017 A KR 20190066017A KR 1020197010823 A KR1020197010823 A KR 1020197010823A KR 20197010823 A KR20197010823 A KR 20197010823A KR 20190066017 A KR20190066017 A KR 20190066017A
Authority
KR
South Korea
Prior art keywords
virus
sampling
probe
cfi
continuous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020197010823A
Other languages
English (en)
Korean (ko)
Inventor
벤자민 마이저
페터 슈반
라우라 다비드
마르틴 로베단
Original Assignee
바이엘 악티엔게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 바이엘 악티엔게젤샤프트 filed Critical 바이엘 악티엔게젤샤프트
Publication of KR20190066017A publication Critical patent/KR20190066017A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/22—Testing for sterility conditions
    • A61L2/0029—
    • A61L2/0082—
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/08—Radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
KR1020197010823A 2016-10-21 2017-10-19 연속식 바이러스 제거의 검증 Ceased KR20190066017A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16194959.9 2016-10-21
EP16194959.9A EP3141611A3 (en) 2016-10-21 2016-10-21 Validation of continuous viral clearance
PCT/US2017/057298 WO2018075716A1 (en) 2016-10-21 2017-10-19 Validation of continuous viral clearance

Publications (1)

Publication Number Publication Date
KR20190066017A true KR20190066017A (ko) 2019-06-12

Family

ID=57209212

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020197010823A Ceased KR20190066017A (ko) 2016-10-21 2017-10-19 연속식 바이러스 제거의 검증

Country Status (16)

Country Link
US (1) US10894991B2 (enExample)
EP (2) EP3141611A3 (enExample)
JP (1) JP2019537435A (enExample)
KR (1) KR20190066017A (enExample)
CN (1) CN110100008A (enExample)
AR (1) AR109846A1 (enExample)
AU (1) AU2017345412A1 (enExample)
BR (1) BR112019007835A2 (enExample)
CA (1) CA3041253A1 (enExample)
IL (1) IL266095A (enExample)
MX (1) MX385466B (enExample)
RU (1) RU2755634C2 (enExample)
SG (1) SG10202104023QA (enExample)
TW (1) TW201827830A (enExample)
UY (1) UY37447A (enExample)
WO (1) WO2018075716A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190022654A1 (en) * 2017-07-10 2019-01-24 Baxalta Incorporated Method for incubating liquids
EP4112735A4 (en) * 2020-02-28 2023-09-06 Asahi Kasei Medical Co., Ltd. METHOD FOR EVALUATING VIRAL CLEARANCE PERFORMANCE
WO2022060535A1 (en) * 2020-09-21 2022-03-24 Bayer Healthcare Llc Pathogen clearance system and method
US12203914B2 (en) * 2020-11-12 2025-01-21 Sartorius Bioanalytical Instruments, Inc. Viral clearance evaluation for biological medical product preparation processes
WO2022203044A1 (ja) * 2021-03-26 2022-09-29 旭化成メディカル株式会社 ウイルスクリアランス試験の方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG184833A1 (en) * 2010-04-14 2012-11-29 Emd Millipore Corp Methods of producing high titer, high purity virus stocks and methods of use thereof
AU2014100888A4 (en) * 2014-08-07 2014-09-11 Novartis Ag Virus clearance and protein purification methods

Also Published As

Publication number Publication date
US20190316213A1 (en) 2019-10-17
IL266095A (en) 2019-06-30
EP3529367A1 (en) 2019-08-28
SG10202104023QA (en) 2021-06-29
EP3141611A2 (en) 2017-03-15
TW201827830A (zh) 2018-08-01
WO2018075716A1 (en) 2018-04-26
BR112019007835A2 (pt) 2019-10-01
RU2019115375A3 (enExample) 2021-03-19
UY37447A (es) 2018-05-31
US10894991B2 (en) 2021-01-19
EP3141611A3 (en) 2017-05-10
CA3041253A1 (en) 2018-04-26
AR109846A1 (es) 2019-01-30
JP2019537435A (ja) 2019-12-26
MX385466B (es) 2025-03-18
CN110100008A (zh) 2019-08-06
AU2017345412A1 (en) 2019-04-18
RU2755634C2 (ru) 2021-09-17
MX2019004540A (es) 2019-06-12
RU2019115375A (ru) 2020-11-23

Similar Documents

Publication Publication Date Title
US10894991B2 (en) Validation of continuous viral clearance
US20180346957A1 (en) High throughput quantification and characterization of foot and mouth disease virus and products thereof
EP3395825B1 (en) Real time monitoring and control of protein production processes using impedance spectroscopy
Jiang et al. Evaluation of a completely automated cold fiber device using compounds with varying volatility and polarity
KR100230560B1 (ko) 펩티드, 폴리누클레오티드 또는 올리고사카라이드 같은 거대분자의 이질상 합성 방법 및 장치
CN113330028A (zh) 将分批制备方法转移至连续制备方法的方法
Theillet et al. Comparative study of chikungunya Virus-Like Particles and Pseudotyped-Particles used for serological detection of specific immunoglobulin M
KR20220114019A (ko) 환경 친화적 세제에 의한 바이러스 불활성화 방법
Park et al. Performance of hollow‐fiber flow field‐flow fractionation in protein separation
HK40011645A (zh) 连续病毒清除的验证
CN106153748B (zh) 一种检测多肽中n,n-二异丙基碳二亚胺的方法
CN104160019A (zh) 使用离心辅助的感染以增加病毒滴度
CN109628563A (zh) 检测piga基因启动子区域4972a>g突变位点的引物、试剂盒和方法
US20050123921A1 (en) Method of purifying oxidatively injured guanine nucleoside, method of measuring the same and analyzer for the embodiment thereof
JP6677737B2 (ja) キャピラリーゾーン電気泳動を用いたウイルス粒子の定量方法
CN109387581B (zh) 一种口蹄疫抗原的定量方法
Jungbauer-Groznica et al. Detection and characterization of single SARS-CoV-2 viral particles by flow virometry
EP4610645A1 (en) Methods for processing and/or purification of a biological product involving multi-angle light scattering as analytical tool for process control
WO2025166281A1 (en) Platform for charge-detection mass spectrometry analysis of aavs
EP4317460B1 (en) VIRAL CLEARANCE TEST PROCEDURE
JP2024509716A (ja) 生化学医療診断キット
US20070134666A1 (en) Simultneous analytical method for oxidatively damaged guanine compound and concentration correcting substance thereof, and analyzer used for this analytical method
WO2026067699A1 (zh) 测定苯甲醇残留量的方法及其应用
Kamphuis et al. Potency testing of inactivated rabies vaccines using a serological method
CN106053644A (zh) 一种医疗美容整形材料奥美定检测方法

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000